Atlas Trials

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Clinical trial NCT04115410 · UNKNOWN

Trial details

NCT number
NCT04115410
Sponsor
Sungkyunkwan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell LungImmune-Related Adverse Events
Start date
2020-07-01
Primary completion
2021-09-23
Enrollment
4724

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.